Pakistan, July 23 -- Pakistan and China have signed 22 investment agreements worth approximately $629.5 million during the Pakistan-China Pharmaceutical & Healthcare B2B Investment Conference, marking a major step towards strengthening bilateral cooperation in the healthcare and pharmaceutical sectors.

Read More: Islamabad opens two-day Pakistan, China health care investment

Addressing a press conference in Islamabad, Federal Minister for National Health Services Syed Mustafa Kamal said the agreements were finalised during the two-day conference held on July 17-18. The deals cover key areas including vaccine production, active pharmaceutical ingredients (APIs), medical devices, clinical trials, and pharmaceutical manufacturing.

The min...